Výsledky vyhledávání

Akademický článek

Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model.

Autor: Barsheshet Y; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Voloshin T; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Brant B; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Cohen G; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Koren L; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Blatt R; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Cahal S; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Haj Khalil T; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Zemer Tov E; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Paz R; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Klein-Goldberg A; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Tempel-Brami C; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Jacobovitch S; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Volodin A; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Kan T; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Koltun B; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., David C; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Haber A; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Giladi M; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Weinberg U; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel., Palti Y; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Nov 15; Vol. 23 (22). Date of Electronic Publication: 2022 Nov 15.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

P25.11 Evaluation of the Safety of Tumor Treating Fields (TTFields) Application to the Torso – in Vivo Studies

Autor: Davidi, S., Blatt, R., Munster, M., Shteingauz, A., Cahal, S., Giladi, M., Weinberg, U., Palti, Y.

Publikováno v: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S386-S387

Zobrazit plný text záznamu

Akademický článek

In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso.

Autor: Blatt R; Novocure Ltd, Haifa, Israel., Davidi S; Novocure Ltd, Haifa, Israel., Munster M; Novocure Ltd, Haifa, Israel., Shteingauz A; Novocure Ltd, Haifa, Israel., Cahal S; Novocure Ltd, Haifa, Israel., Zeidan A; Novocure Ltd, Haifa, Israel., Marciano T; Novocure Ltd, Haifa, Israel., Bomzon Z; Novocure Ltd, Haifa, Israel., Haber A; Novocure Ltd, Haifa, Israel., Giladi M; Novocure Ltd, Haifa, Israel., Weinberg U; Novocure Ltd, Haifa, Israel., Kinzel A; Novocure GmbH, Munich, Germany., Palti Y; Novocure Ltd, Haifa, Israel.

Publikováno v: Frontiers in oncology [Front Oncol] 2021 Jun 24; Vol. 11, pp. 670809. Date of Electronic Publication: 2021 Jun 24 (Print Publication: 2021).

Zobrazit plný text záznamu

Akademický článek

EP1.06-07 In Vivo Studies of Tumor Treating Fields to Upper Torso in Combination with Chemotherapy Show No Additional Toxicities

Autor: Giladi, M., Davidi, S., Munster, M., Schneiderman, R., Kaynan, N., Voloshin, T., Porat, Y., Cahal, S., Kirson, E., Weinberg, U., Palti, Y.

Publikováno v: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S992-S992

Zobrazit plný text záznamu

Akademický článek

7P - Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models

Autor: Weinberg, U., Kaynan, N., Voloshin Sela, T., Davidi, S., Porat, Y., Shteingauz, A., Munster, M., Schneiderman, R.S., Tempel Brami, C., Zeevi, E., Gotlib, K., Cahal, S., Giladi, M., Kirson, E., Kinzel, A., Palti, Y.

Publikováno v: In Annals of Oncology April 2019 30 Supplement 2:ii2-ii3

Zobrazit plný text záznamu

Akademický článek

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.

Autor: Voloshin T; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Kaynan N; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Davidi S; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Porat Y; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Shteingauz A; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Schneiderman RS; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Zeevi E; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Munster M; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Blat R; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Tempel Brami C; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Cahal S; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Itzhaki A; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Giladi M; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel. mosheg@novocure.com., Kirson ED; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Weinberg U; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel., Kinzel A; Novocure GmbH, Munich, Germany., Palti Y; Novocure Ltd., Topaz Building, MATAM Center, 31905, Haifa, Israel.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Jul; Vol. 69 (7), pp. 1191-1204. Date of Electronic Publication: 2020 Mar 06.

Zobrazit plný text záznamu

Akademický článek

39P - Efficacy of Tumor Treating Fields (TTFields) and anti-PD-1 in non-small cell lung cancer (NSCLC) preclinical models

Autor: Weinberg, U., Voloshin, T., Yitzaki, O.T., Kaynan, N., Giladi, M., Shteingauz, A., Munster, M., Cahal, S., Kirson, E.D., Palti, Y.

Publikováno v: In Annals of Oncology April 2017 28 Supplement 2:ii11-ii12

Zobrazit plný text záznamu

Akademický článek

Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.

Autor: Mrugala MM; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix/Scottsdale, Arizona, USA. Mrugala.Maciej@mayo.edu., Shi W; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA., Iwomoto F; Division of Neuro-Oncology, New York-Presbyterian/Columbia University Medical Center, New York, NY, USA., Lukas RV; Department of Neurology, Northwestern University, Chicago, IL, USA., Palmer JD; The Department of Radiation Oncology, The James Cancer Hospital, Ohio State University Wexner Medical Center, Columbus, OH, USA., Suh JH; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Glas M; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center (WTZ) and German Cancer Consortium, Partner Site, Essen, Germany.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2024 Aug; Vol. 169 (1), pp. 25-38. Date of Electronic Publication: 2024 Jun 29.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání